Recurrent Bladder Cancer - CancerConnect
Frontiers | Detecting and monitoring bladder cancer with exfoliated cells in urine
JCI - Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer
Cancers | Free Full-Text | Noninvasive Urine-Based Tests to Diagnose or Detect Recurrence of Bladder Cancer
Bladder Cancer Biomarkers | Encyclopedia MDPI
Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight - ScienceDirect
Dr. Peter Black | Urine Markers for Bladder Cancer | The Ideal Marker
Frontiers | Urinary Markers in Bladder Cancer: An Update
Useful and potentially useful urine markers for bladder cancer. | Download Table
Gender-specific Differences in Recurrence of Non–muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis - European Urology Focus
Improving Early Detection and Clinical Management of Bladder Cancer
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study - The Lancet Oncology
Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study - eBioMedicine
Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 Hypermethylation | PLOS ONE
Artificial intelligence: A promising frontier in bladder cancer diagnosis and outcome prediction - ScienceDirect
Diagnostics | Free Full-Text | Biomarkers for Bladder Cancer Diagnosis and Surveillance: A Comprehensive Review
Summary of urinary markers for bladder cancer | Download Table
Non muscle invasive bladder cancer treatment - WCRJ
FEP 2.04.07 Urinary Biomarkers for Cancer Screening, Diagnosis, and Surveillance
